Ravindra Kumar, VP & Chief Scientific Officer at ACCELERON PHARMA INC (XLRN), sold 9,000 shares at $32.27 ($282K) on 2014-05-19, disclosed to the SEC on 2014-05-21.
Scheduled sale ($282k) by VP & Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $31.23 | 6,500 | $203K | 71.9% |
| 2 | $31.51 | 1,800 | $57K | 20.1% |
| 3 | $32.13 | 500 | $16K | 5.7% |
| 4 | $32.27 | 200 | $6K | 2.3% |
| Total | $31.36 avg | 9,000 | $282K | 100% |
| Filing → |
| XLRN | SELL | 2019-01-04 | $249K | — | Filing → |
| XLRN | SELL | 2018-04-04 | $46K | — | Filing → |
| XLRN | SELL | 2018-01-04 | $182K | — | Filing → |